InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.11
(
0.57%
)
Bitcoin
91,521.24
(
1.84%
)
Post# of 10237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

califax

Send PM Follow Ignore
Followers 24
Posts 3015
Boards Moderated 0
Alias Born 01/18/2009

califax

Re: califax post# 7155

Friday, 02/19/2010 8:15:20 AM

Friday, February 19, 2010 8:15:20 AM

Post# of 10237
NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland

- Positive Clinical Results from Pivotal Study of H1N1 Virus-Like Particle (VLP) Pandemic Influenza Vaccine in
- Immunogenicity responses at all dose levels meet U.S. and European regulatory authorities recommended criteria for seroconversion and seroprotection
- More than fifty percent of the volunteers already enrolled in Stage B of study

Novavax, Inc. On Friday February 19, 2010, 6:00 am EST

http://finance.yahoo.com/news/NOVAVAX-Presents-Positive-prnews-202400648.html?x=0&.v=1

posts are IMHO // either news - with LINK

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up